🟢 MiniMed Group is trading 4.05% up in pre-market after BofA lifted price target to $24

MiniMed Group is trading at $20.58 (+4.05%) after BofA Securities raised its price target to $24 from $20 while maintaining a Buy rating.

• BofA cited the approaching potential window for Medtronic to exchange its 90% ownership stake for Medtronic shares.
• Broader indexes are modestly higher, while the analyst action and exchange potential are the clearest catalysts.